Testing the NHS: the tensions between personalized and collective medicine produced by personal genomics in the UK

References

• AGNC. 2014. The Future Role of Genetic Counsellors in Genomic Healthcare. Association of Genetic Nurses and Counsellors. Accessed April 13, 2017. http://www.agnc.org.uk/media/925792/agnc_vision_statement_final.pdf.
   Google Scholar
• Arribas-Ayllon, M., S. Sarangi, and A. Clarke. 2011. “Promissory Accounts of Personalisation in the Commercialisation of Genomic Knowledge.” Communication and Medicine 8 (1): 53–66. doi: 10.1558/cam.v8i1.53
   Google Scholar
• Atkinson, R., and J. Flint. 2001. “Accessing Hidden and Hard-to-reach Populations: Snowball Research Strategies.” Social Research Update 33. Accessed April 4, 2016. http://sru.soc.surrey.ac.uk/SRU33.html.
   Google Scholar
• Bambra, C. 2013. “All in it Together? Health Inequalities, Austerity and the ‘Great Recession’.” In Health in Austerity, edited by C. Wood. London: Demos. Accessed April 4, 2017. https://www.demos.co.uk/files/DEMOS_Health_in_Austerity_-_web.pdf?1379898927.
   Google Scholar
• Bartley, M. 1990. “Do We Need a Strong Programme in Medical Sociology?” Sociology of Health and Illness 12 (4): 371–390. doi: 10.1111/1467-9566.ep11340397
   Web of Science ®Google Scholar
• Bijker, W. E. 2010. “How is Technology Made? That is the Question!” Cambridge Journal of Economics 34: 63–76. doi: 10.1093/cje/bep068
   Web of Science ®Google Scholar
• Bijker, W. E., T. P. Hughes, and T. Pinch. 2012. The Social Construction of Technological Systems: New Directions in the Sociology and History of Technology. Anniversary ed. Cambridge, MA: MIT Press.
   Google Scholar
• Borry, P., M. C. Cornel, and H. C. Howard. 2010. “Where are you Going, Where Have You Been: A Recent History of the Direct-to-consumer Genetic Testing Market.” Journal of Community Genetics 1 (3): 101–106. Accessed September 4, 2016. http://www.springerlink.com/content/1uk1w43425251412/. doi: 10.1007/s12687-010-0023-z
   PubMedGoogle Scholar
• Brown, N., and A. Webster. 2004. New Medical Technologies and Society: Re-ordering Life. Cambridge: Polity Press.
   Google Scholar
• Bunnik, E. M., J. W. Janssens, and M. H. N. Schermer. 2015. “Personal Utility in Genomic Testing: Is There Such a Thing?” Journal of Medical Ethics 41 (4): 322–326. doi: 10.1136/medethics-2013-101887
   PubMed Web of Science ®Google Scholar
• Busby, H., and P. Martin. 2006. “Biobanks, National Identity and Imagined Communities: The Case of UK Biobank.” Science as Culture 15 (3): 237–251. doi:10.1080/09505430600890693 doi: 10.1080/09505430600890693
   Google Scholar
• Carere, D. A., P. Kraft, K. A. Kaphingst, J. S. Roberts, and R. C. Green. 2016. “Consumers Report Lower Confidence in Their Genetics Knowledge Following Direct-to-consumer Personal Genomic Testing.” Genetics in Medicine 18 (1): 65–72. doi: 10.1038/gim.2015.34
   PubMed Web of Science ®Google Scholar
• Cherkas, L., J. Harris, E. Levinson, T. Spector, and B. Prainsack. 2010. “A Survey of UK Public Interest in Internet-based Personal Genome Testing.” PLoS One 5 (10): e13473. doi: 10.1371/journal.pone.0013473
   PubMed Web of Science ®Google Scholar
• Chilibeck, G., M. Lock, and M. Sehdev. 2011. “Postgenomics, Uncertain Futures and the Familiarization of Susceptibility Genes.” Social Science and Medicine 72: 1768–1775. doi: 10.1016/j.socscimed.2010.01.053
   PubMed Web of Science ®Google Scholar
• Clayton-Smith, J., R. Newbury-Ecob, J. Cook, and L. Greenhalgh. 2015. The Evolving Role of the Clinical Geneticist. Clinical Genetics Society. Accessed April 13, 2017. http://www.bsgm.org.uk/media/956131/theevolvingroleoftheclinicalgeneticist_29.07.15.pdf.
   Google Scholar
• Coffey, A., and P. Atkinson. 1996. Making Sense of Qualitative Data: Complementary Research Strategies. Thousand Oaks, CA: Sage.
   Google Scholar
• Collins, H., and R. Evans. 2007. Rethinking Expertise. London: University of Chicago Press.
   Google Scholar
• Collins, R. E., A. J. Wright, and T. M. Marteau. 2011. “Impact of Communicating Personalized Risk Information on Perceived Control Over the Risk: A Systematic Review.” Genetics in Medicine 13 (4): 273–277. doi: 10.1097/GIM.0b013e3181f710ca
   PubMed Web of Science ®Google Scholar
• Conley, J. 2013. If 23andMe falls in the forest, and there’s no-one there … Genomics Law Report Accessed September 4, 2016. http://www.genomicslawreport.com/index.php/2013/12/03/if-23andme-falls-in-the-forest-and-theres-no-one-there/#more-13198.
   Google Scholar
• Creswell, J. W. 2013. Qualitative Inquiry and Research Design: Choosing among Five Approaches. Los Angeles: Sage.
   Google Scholar
• Department of Health. 2010. Healthy Lives, Healthy People: Our Strategy for Public Health in England. Department of Health, The Stationery Office. Accessed March 15, 2017. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/216096/dh_127424.pdf.
   Google Scholar
• Dickenson, D. 2013. Me Medicine vs. We Medicine: Reclaiming Biotechnology for the Common Good. New York, NY: Columbia University Press.
   Google Scholar
• Edleman, E., and C. Eng. (2009). “A Practical Guide to Interpretation and Clinical Application of Personal Genomic Screening.” British Medical Journal 339: 1136–1140.
   Google Scholar
• Epstein, S. 1995. “The Construction of Lay Expertise: AIDS Activism and the Forging of Credibility in the Reform of Clinical Trials.” Science, Technology and Human Values 20 (4): 408–437. doi: 10.1177/016224399502000402
   PubMed Web of Science ®Google Scholar
• Evans, J. P., and R. C. Green. 2009. “Direct-to-consumer Genetic Testing: Avoiding a Culture War.” Genetics in Medicine 11 (8): 568–569. doi: 10.1097/GIM.0b013e3181afbaed
   PubMed Web of Science ®Google Scholar
• Evans, R., and A. Plows. 2007. “Listening Without Prejudice? Rediscovering the Value of the Disinterested Citizen.” Social Studies of Science 37 (6): 827–853. doi: 10.1177/0306312707076602
   Web of Science ®Google Scholar
• Finlay, T., S. Gibson, L. Koch, and S. Tocchetti. 2016. “Personal Genomics: Transparent to Whom?” In Genetic Transparency: Ethical and Social Implications of Next Generation Human Genomics and Genetic Medicine, edited by M. Dreyer, J. Erdmann, and C. Rehmann-Sutter, 113–146. Amsterdam: Brill Rodopi.
   Google Scholar
• Genomesunzipped. n.d. Genomesunzipped: Public Personal Genomics. Accessed April 13, 2014. http://genomesunzipped.org/about.
   Google Scholar
• Genomics England. n.d. The 100,000 Genomes Project. Accessed April 13, 2017. https://www.genomicsengland.co.uk/.
   Google Scholar
• Gershlick, B., A. Charlesworth, E. Taylor. (2015). Public Attitudes to the NHS. London: The Health Foundation. Accessed March 30, 2017. http://www.health.org.uk/sites/health/files/PublicAttitudesToTheNHS.pdf.
   Google Scholar
• Gray, S. W., C. O’Grady, L. Karp, D. Smith, J. Sanford Schwartz, R. C. Hornick, and K. Armstrong. 2009. “Risk Information Exposure and Direct-to- Consumer Genetic Testing for BRCA Mutations Among Women with a Personal or Family History of Breast or Ovarian Cancer.” Cancer Epidemiology, Biomarkers and Prevention 18 (3): 1303–1311. doi: 10.1158/1055-9965.EPI-08-0825
   PubMed Web of Science ®Google Scholar
• Harris, A., S. Kelly, and S. Wyatt. 2016. Cybergenetics: Health Genetics and New Media. Abingdon: Routledge.
   Google Scholar
• Hedgecoe, A. M., and P. A. Martin. 2003. “The Drugs don’t Work: Expectations and the Shaping of Pharmacogenetics.” Social Studies of Science 33 (3): 327–364. doi: 10.1177/03063127030333002
   PubMed Web of Science ®Google Scholar
• Hogarth, S., G. Javitt, and D. Melzer. 2008. “The Current Landscape for Direct-to-consumer Genetic Testing: Legal, Ethical and Policy Issues.” Annual Review of Genomics and Human Genetics 9: 161–182. doi: 10.1146/annurev.genom.9.081307.164319
   PubMed Web of Science ®Google Scholar
• Janssens, A. C. J. W., M. Gwinn, L. A. Bradley, B. A. Oostra, C. M. van Duijn, and M. J. Khoury. 2008. “A Critical Appraisal of the Scientific Basis of Commercial Genome Profiles Used to Assess Health Risks and Personalize Health Interventions.” American Journal of Human Genetics 82: 593–599. doi: 10.1016/j.ajhg.2007.12.020
   PubMed Web of Science ®Google Scholar
• Jordens, C. F. C., I. H. Kerridge, and G. N. Samuel. 2009. “Direct-to-consumer Personal Genome Testing: The Problem is not Ignorance – It Is Market Failure.” American Journal of Bioethics 9 (6–7): 13–15. doi: 10.1080/15265160902874411
   PubMed Web of Science ®Google Scholar
• Juengst, E. T., M. A. Flatt, and R. A. Settersten. 2012. “Personalized Genomic Medicine and the Rhetoric of Empowerment.” Hastings Centre Report 42 (5): 34–40. doi: 10.1002/hast.65
   PubMed Web of Science ®Google Scholar
• Kerr, A., S. Cunningham-Burley, and A. Amos. 1998. “The New Genetics and Health: Mobilizing Lay Expertise.” Public Understanding of Science 7: 41–60. doi:10.1177/096366259800700104.
   PubMed Web of Science ®Google Scholar
• Klein, R. (2013). The New Politics of the NHS: From Creation to Reinvention. 7th ed. Abingdon: Radcliffe Publishing.
   Google Scholar
• Klein, H. K., and D. L. Kleinman. 2002. “The Social Construction of Technology: Structural Considerations.” Science, Technology and Human Values 27 (1): 28–52. doi: 10.1177/016224390202700102
   Web of Science ®Google Scholar
• Kraft, P., and D. J. Hunter. 2009. “Genetic Risk Prediction? Are We There Yet?” New England Journal of Medicine 360 (17): 1701–1703. doi: 10.1056/NEJMp0810107
   PubMed Web of Science ®Google Scholar
• Lachance, C. R., L. A. H. Erby, B. M. Ford, V. C. Allen, and K. A. Kaphingst. 2010. “Informational Content, Literacy Demands, and Usability of Websites Offering Health-related Genetic Tests Directly to Consumers.” Genetics in Medicine 12 (5): 304–312. doi: 10.1097/GIM.0b013e3181dbd8b2
   PubMed Web of Science ®Google Scholar
• Leachman, S. A., D. G. MacArthur, M. Angrist, S. W. Gray, A. R. Bradbury, and D. B. Vorhaus. 2011. “Direct-to-consumer Genetic Testing: Personalized Medicine in Evolution.” In ASCO Education Book, 34–40. https://www.genomicslawreport.com/wp-content/uploads/2011/06/ASCO-DTC-Abstract.pdf.
   Google Scholar
• Leighton, J. W., K. Valverde, and B. A. Bernhardt. 2012. “The General Public’s Understanding and Perception of Direct-to-consumer Genetic Test Results.” Public Health Genomics 15 (1): 11–21. doi: 10.1159/000327159
   PubMed Web of Science ®Google Scholar
• Lessa, I. 2005. “Discursive Struggles with Social Welfare: Restaging Teen Motherhood.” British Journal of Social Work 36 (2): 283–298. doi: 10.1093/bjsw/bch256
   Web of Science ®Google Scholar
• Louden, I. 2008. “The Principle of Referral: The Gatekeeping Role of the GP.” British Journal of General Practice 58 (547): 128–130. doi: 10.3399/bjgp08X277113
   PubMed Web of Science ®Google Scholar
• Lynch, M., S. A. Cole, R. McNally, and K. Jordan. 2010. Truth Machine: The Contentious History of DNA Fingerprinting. Chicago, IL: University of Chicago Press.
   Google Scholar
• McGowan, M. L., J. R. Fishman, and M. A. Lambrix. 2010. “Personal Genomics and Individual Identities: Motivations and Moral Imperatives of Early Users.” New Genetics and Society 29 (3): 261–290. doi: 10.1080/14636778.2010.507485
   PubMed Web of Science ®Google Scholar
• McGuire, A. L., and W. Burke. 2008. “An Unwelcome Side-effect of Direct-to-consumer Personal Genetic Testing: Raiding the Medical Commons.” Journal of the American Medical Association 300 (22): 2669–2671. doi: 10.1001/jama.2008.803
   PubMed Web of Science ®Google Scholar
• McGuire, A. L., C. M. Diaz, T. Wang, and S. G. Hilsenbeck. 2009. “Social Networkers’ Attitudes to Direct-to-consumer Personal Genome Testing.” American Journal of Bioethics 9 (6–7): 3–10. doi: 10.1080/15265160902928209
   PubMed Web of Science ®Google Scholar
• Nuffield Council on Bioethics. 2010. Medical Profiling and Online Medicine: the Ethics of Personalised Healthcare in a Consumer Age. London: Nuffield Centre for Bioethics. Accessed April 4, 2017. http://www.nuffieldbioethics.org/personalised-healthcare-0.
   Google Scholar
• Potter, R. J., and M. Mulkay. 1985. “Scientists’ Interview Talk: Interviews as a Technique for Revealing Participants’ Interpretative Practices.” In The Research Interview: Uses and Approaches, edited by M. Brenner, J. Brown, and D. Canter, 247–271. London: Academic Press.
   Google Scholar
• Prainsack, B., J. Reardon, R. Hindmarsh, H. Gottweis, U. Naue, and J. E. Lunshof. 2008. “Personal Genomes: Misdirected Precaution.” Nature 456: 34–35. doi: 10.1038/456034a
   PubMed Web of Science ®Google Scholar
• Prior, L. 2003. “Belief, Knowledge and Expertise: The Emergence of the Lay Expert in Medical Sociology.” Sociology of Health and Illness 25 (3): 41–57. doi: 10.1111/1467-9566.00339
   PubMed Web of Science ®Google Scholar
• Public Health England. (2016). Prostate Cancer Risk Management: Programme Benefits and Risks of PSA Testing. Public Health England Gov.UK. Accessed April 15, 2017. https://www.gov.uk/government/publications/prostate-cancer-risk-management-programme-psa-test-benefits-and-risks/prostate-cancer-risk-management-programme-pcrmp-benefits-and-risks-of-psa-testing#references.
   Google Scholar
• Ryan, G. W., and H. R. Bernard. (2000). “Data Management and Analysis Methods.” In Handbook of Qualitative Research, edited by N. K. Denzin and Y. S. Lincoln, 2nd ed, 769–802. Thousand Oaks, CA: Sage.
   Google Scholar
• Salari, K. (2009). “The Dawning Era of Personalised Medicine Exposes a Gap in Medical Education.” PLoS Medicine 6 (8): e1000138. Accessed April 4, 2017. http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1000138. doi: 10.1371/journal.pmed.1000138
   PubMed Web of Science ®Google Scholar
• Saukko, P. M., M. Reed, N. Britten, and S. Hogarth. 2010. “Negotiating the Boundary Between Medicine and Consumer Culture: Online Marketing of Nutrigenomic Tests.” Social Science and Medicine 70 (5): 744–753. doi: 10.1016/j.socscimed.2009.10.066
   PubMed Web of Science ®Google Scholar
• Singleton, A., L. H. Erby, K. V. Foisie, and K. A. Kaphingst. 2012. “Informed Choice in Direct-to-consumer Genetic Tests (DTCGT) Websites: A Content Analysis of Benefits, Risks and Limitations.” Journal of Genetic Counseling 21: 433–439. doi: 10.1007/s10897-011-9474-6
   PubMed Web of Science ®Google Scholar
• Stergiopoulos, K., and D. L. Brown. 2014. “Genotype-guided Versus Clinical Dosing of Warfarin and Its Analogues: Meta-analysis of Randomized Clinical Trials.” Journal of the American Medical Association Internal Medicine 174 (8): 1330–1338. doi:10.1001/jamainternmed.2014.2368.
   Google Scholar
• Tutton, R. 2012. “Personalizing Medicine: Futures Present and Past.” Social Science and Medicine 75 (10): 1721–1728. doi: 10.1016/j.socscimed.2012.07.031
   PubMed Web of Science ®Google Scholar
• Tutton, R. 2014. Genomics and the Reimagining of Personalized Medicine. Farnham: Ashgate.
   Google Scholar
• Tutton, R., and B. Prainsack. 2011. “Enterprising or Altruistic Selves? Making Up Research Subjects in Genetic Research.” Sociology of Health and Illness 33 (7): 1081–1095. doi: 10.1111/j.1467-9566.2011.01348.x
   PubMed Web of Science ®Google Scholar
• UK Pharmacogenetics Study Group. (2006). Policy Issues in Pharmacogenetics: Policy Briefing. Accessed April 17, 2017. http://www.york.ac.uk/media/satsu/res-pgx/PGxpolicyissues2006.pdf.
   Google Scholar
• Van Lente, H. 2000. “Forceful Futures: From Promise to Requirement.” In Contested Futures: A Sociology of Prospective Technoscience, edited by N. Brown, B. Rappert, and A. Webster, 43–64. Aldershot: Ashgate.
   Google Scholar
• Vayena, E., E. Gourna, J. Streuli, E. Hafen, and B. Prainsack. 2012. “Experiences of Early Users of Direct-to-consumer Genomics in Switzerland: An Exploratory Study.” Public Health Genomics 15: 352–362. doi.org/10.1159/000343792 doi: 10.1159/000343792
   PubMed Web of Science ®Google Scholar
• Vorhaus, D. 2012. “Implications of Amgen/deCODE Deal for Genetic Testing Consumers.” Genomics Law Report. Accessed April 17, 2017 http://www.genomicslawreport.com/index.php/2012/12/10/implications-of-amgendecode-deal-for-genetic-testing-consumers/.
   Google Scholar
• Williams, R., and D. Edge. 1996. “The Social Shaping of Technology.” Research Policy 25: 865–899. doi: 10.1016/0048-7333(96)00885-2
   Web of Science ®Google Scholar
• Wright, C., H. Burton, A. Hall, S. Moorthie, A. Pokorska-Bocci, G. Sagoo, S. Sanderson, R. Skinner. 2011. Next Steps in the Sequence: The Implications of Whole Genome Sequencing for Health in the UK. PHG Foundation Cambridge. Accessed September 4, 2016. http://www.phgfoundation.org/file/10363/.
   Google Scholar
• Wyatt, S. (2008). “Technological Determinism is Dead; Long Live Technological Determinism.” In The Handbook of Science and Technology Studies, edited by I. Hackett, O. Amsterdamska, M. Lynch, and J. Wajcman, 3rd ed., 165–180. Cambridge, MA: MIT Press.
   Google Scholar
• Wyatt, S., A. Harris, S. Adams, and S. Kelly. 2013. “Illness Online: Self-reported Data and Questions of Trust in Medical and Social Research.” Theory, Culture and Society 30 (4): 131–150. doi: 10.1177/0263276413485900
   Web of Science ®Google Scholar